MassRoots, Inc. (OTCQB:MSRT) , one of the leading publicly-traded cannabis technology companies, and Grownetics, a leader in cultivation automation and optimization for the cannabis industry, are pleased to announce they are partnering to aggregate data collected throughout the cannabis supply chain to provide reports and analysis to cannabis businesses.
“Over the past year, we have worked diligently to develop the functionality to allow cannabis consumers to review the products they purchase in dispensaries. By comparing this information with the millions of data points collected by the Grownetics system, both companies could be able to provide invaluable information at the strain level to our business clients,” stated MassRoots Chief Executive Officer Isaac Dietrich. “We believe this analysis will be some of the most comprehensive and innovative reporting ever offered about specific strains and products in the cannabis industry.”
Grownetics, which is headquartered at the Boomtown Accelerator in Boulder, CO, is developing a sophisticated automation system for cannabis cultivators and could be the future of agricultural artificial intelligence. By combining big data and machine learning optimization algorithms, the company helps growers reduce costs, decrease energy usage, and increase overall quality and yield based on strain.
“We’re extremely excited about this partnership with MassRoots. Until this point, our team has strived to developed the most effective and innovative cultivation system on the market,” added Eli Duffy, Grownetics CEO. “Partnering with MassRoots will allow us to leverage their connections and expertise to scale our technology and become the most dominant cultivation technology company in the cannabis industry.”
MassRoots announced in January that it closed an acquisition of DDDigital, Inc. d.b.a. “Whaxy,” a menu management and online ordering system for medical and adult-use dispensaries. By correlating the data collected by this system with the data collected by MassRoots’ social platform and by Grownetics, there is significant potential for meaningful analysis.
“Grownetics’ value proposition to cannabis cultivation facilities is clear — it allows them to increase yields with less resources,” continued Dietrich. “We believe the partnership creates a value-add to our offerings to businesses.”
Based on initial data with their first customer, The Flower Collective, Grownetics’ technology could provide up to a 60% reduction in operating costs. These results have been validated by the University of Colorado’s Leeds School of Business Entrepreneurial Solutions team. The technology has been used by Ph.D researchers in California to optimize indoor cultivation.
The strategic alliance with Grownetics complements the recently announced partnership between MassRoots and New Frontier Data, and could amplify the depth and extent of analysis provided to cannabis business cultivators, retailers, and consumers.
About MassRoots, Inc.
MassRoots is one of the largest technology platforms for the regulated cannabis industry. The Company’s mobile apps enable consumers to make educated cannabis purchasing decisions through community-driven reviews. MassRoots is proud to be affiliated with the leading businesses and organizations in the cannabis industry, including the ArcView Group and National Cannabis Industry Association. For more information, please visit MassRoots.com/Investors.
About Grownetics
Grownetics™ is a cultivation technology company which has built fully automated smart thinking garden.  By combining big data and machine learning, Grownetic’s helps growers decrease their costs, increase their plant’s yields, and save valuable resources.  In 2016, Grownetics was awarded both the Cannabist’s award for best cannabis technology startup and best technology company in the University of Colorado’s New Venture Challenge.
Forward-looking Statements
Certain matters discussed in this announcement contain statements, estimates and projections about the growth of MassRoots’ business, potential partnerships, new features, and related business strategy. Such statements, estimates and projections may constitute forward-looking statements within the meaning of the federal securities laws. Factors or events that could cause our actual results to differ may emerge from time to time. MassRoots undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The recipient of this information is cautioned not to place undue reliance on forward-looking statements.
Click here to connect with MassRoots, Inc. (OTCQB:MSRT) to receive an Investor Presentation.

Source: www.prnewswire.com

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less